← Leaderboards
Jason Wright
Columbia University Health Sciences
$4,496,895
Attributed
$10,012,335
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,012,335 · 4
By mechanism
R01$5,840,921 · 3
U01$4,171,414 · 1
Top collaborators
- Nina A Bickell5 shared
- Stephanie V. Blank5 shared
- Elena B Elkin5 shared
- Laura J Havrilesky5 shared
- Chung Yin Kong5 shared
- Pari Vijay Pandharipande5 shared
- Xiao Xu5 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Cristiane S Duarte$13,421,746
- Jennifer Jaie Manly$44,501,207
- Bernadette Marie Boden-Albala$14,871,232
- Timothy J Wilkin$15,325,032
- Stephanie V. Blank$695,236
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCharacteristicsAffectResourcesWomanFutureTumorNewly DiagnosedCostWomen&AposDiagnosisDatabasesCaringProviderRecommendationDecision MakingDeath RateNew Therapeutic TargetOperative Surgical ProceduresComorbidityCancer EtiologyTreatment StrategyEffectivenessIncidence
Grant awards (20)
Comparative Modeling for the Prevention and Control of Uterine Cancer$630,059
U01 · FY2025 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$480,691
R01 · FY2025 · CA
Improving Treatment Selection in Advanced Ovarian Cancer$76,654
R01 · FY2025 · CA
Comparative Modeling for the Prevention and Control of Uterine Cancer$803,402
U01 · FY2024 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$530,073
R01 · FY2024 · CA
Racial Disparity in Diagnostic Evaluation of Uterine Cancer$232,654
R01 · FY2024 · MD
Comparative Modeling for the Prevention and Control of Uterine Cancer$856,073
U01 · FY2023 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$532,652
R01 · FY2023 · CA
Racial Disparity in Diagnostic Evaluation of Uterine Cancer$336,989
R01 · FY2023 · MD
Racial Disparity in Diagnostic Evaluation of Uterine Cancer$35,243
R01 · FY2023 · MD
Comparative Modeling for the Prevention and Control of Uterine Cancer$933,993
U01 · FY2022 · CA · contact PI
Improving Treatment Selection in Advanced Ovarian Cancer$640,635
R01 · FY2022 · CA
Racial Disparity in Diagnostic Evaluation of Uterine Cancer$557,965
R01 · FY2022 · MD
Comparative Modeling for the Prevention and Control of Uterine Cancer$947,887
U01 · FY2021 · CA · contact PI
Racial Disparity in Diagnostic Evaluation of Uterine Cancer$654,967
R01 · FY2021 · MD
The Influence of Hospital Variability on the Management of Cancer-Associated Comp$332,000
R01 · FY2017 · CA · contact PI
The Influence of Hospital Variability on the Management of Cancer-Associated Comp$444,358
R01 · FY2016 · CA · contact PI
The Influence of Hospital Variability on the Management of Cancer-Associated Comp$332,000
R01 · FY2015 · CA · contact PI
The Influence of Hospital Variability on the Management of Cancer-Associated Comp$322,040
R01 · FY2014 · CA · contact PI
The Influence of Hospital Variability on the Management of Cancer-Associated Comp$332,000
R01 · FY2013 · CA · contact PI